Interní Med. 2011; 13(5): 199-201

Diabetes and vascular disease

MUDr.Alena Broulíková, CSc.
III. interní klinika 1. LF UK Praha a VFN, Praha

Vascular disease is the leading cause of morbidity and mortality in people with diabetes. The diabetic process leads to both accelerated

form of atherosclerosis affecting arteries of all sizes (large vessel disease or macroangiopathy) and to a specific microangiopathy

characterised by basement membrane thickening inm capillaries, arterioles and venules. Large vessel disease accounts for the excess of

coronary artery, cerebrovascular and peripheral vascular disease, whereas microangiopathy contributes mainly to diabetes retinopathy

and nephropathy and partly also to neuropathy. Diabetic foot problems are due to a combination of ischaemia and neuropathy, often

complicated by infection. As foot ulcers usually take many weeks or months to heal, they are a major burden for the diabetic, their family

and the health care team from physical, psychological and financial perspectives.

macroangiopathy, diabetic foot syndrome.

Keywords: atherosclerosis, diabetes mellitus, peripheral artery occlusive disease of lower extremities, diabetic microangiopathy and

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Broulíková A. Diabetes and vascular disease. Interní Med. 2011;13(5):199-201.
Download citation

References

  1. Škrha J, a kol. Diabetologie. Praha: Galén, 2009: 64-75.
  2. Škrha J. Oxidační stres a jeho vztah ke komplikacím diabetu. Interní Med. 2010; 12(9): 414-418.
  3. Vinik Al Erban T, Parks TS, et al. Platellet dysfunction in type II diabetes. Diabetes Care 2001; 24: 1476-1485. Go to original source... Go to PubMed...
  4. Fisman EZ, Tenenbaum A, et al. Cardiovascular diabetology. Advances in cardiology Basel: Karger 2008; 45. Go to original source... Go to PubMed...
  5. Kannel WB, McGee, DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038. Go to original source... Go to PubMed...
  6. Stamler J, et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444. Go to original source... Go to PubMed...
  7. Perušičová J. Jak ovlivňují diabetes mellitus 2. typu a zvýšená glykémie kardiovaskulární riziko? Kardiol Rev 2009; 11(3): 117-121.
  8. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Int Med, 2004; 141: 421-431. Go to original source... Go to PubMed...
  9. European working group on critical leg ischaemia. Second European consensus document on chronic critical leg ischaemia. Circulation 1991; 84(Suppl IV): 1-26.
  10. Mezinárodní pracovní skupina pro syndrom diabetické nohy. Syndrom diabetické nohy. Mezinárodní konsensus. Praha: Galén, 2000.
  11. Jirkovská A, a kol. Syndrom diabetické nohy. Komplexní týmová péče. Praha: Maxdorf, 2006; 29-35.
  12. Broulíková A, Krupičková Z. Ischemická choroba dolních končetin. In: Škrha J, a kol. Diabetologie. Praha: Galén, 2009: 230-241.
  13. Kvapil M., ,Nová diabetologie" a epidemie diabetu. Lékařské listy 2009; 4: 3-4.
  14. Lacigová S, Rušavý Z. Základní informace o diagnostice a léčbě diabetu a jeho komplikacích pro nediabetology. Lékařské listy 2008; 17: 15-18.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.